Intervention Review

Hormone replacement therapy to maintain cognitive function in women with dementia

  1. Eva Hogervorst1,*,
  2. Kristine Yaffe2,
  3. Marcus Richards3,
  4. Felicia AH Huppert4

Editorial Group: Cochrane Dementia and Cognitive Improvement Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 8 APR 2008

DOI: 10.1002/14651858.CD003799.pub2


How to Cite

Hogervorst E, Yaffe K, Richards M, Huppert FAH. Hormone replacement therapy to maintain cognitive function in women with dementia. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD003799. DOI: 10.1002/14651858.CD003799.pub2.

Author Information

  1. 1

    Loughborough University, Department of Human Sciences, Loughborough, Leicestershire, UK

  2. 2

    University of California, San Francisco, Psychiatry, Neurology and Epidemiology, San Francisco, California, USA

  3. 3

    University College London Department of Epidemiology & Public Health, London, UK

  4. 4

    University of Cambridge, Department of Psychiatry, Cambridge, UK

*Eva Hogervorst, Department of Human Sciences, Loughborough University, Loughborough, Leicestershire, LE11 3TU, UK. E.Hogervorst@lboro.ac.uk .

Publication History

  1. Publication Status: Edited (conclusions changed)
  2. Published Online: 21 JAN 2009

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ke Li, Xiaoyan Huang, Yingping Han, Jun Zhang, Yuhan Lai, Li Yuan, Jiaojiao Lu, Dong Zeng, Enhanced Neuroactivation during Working Memory Task in Postmenopausal Women Receiving Hormone Therapy: A Coordinate-Based Meta-Analysis, Frontiers in Human Neuroscience, 2015, 9,

    CrossRef

  2. 2
    Michael Hüll, Hans Förstl, Psychische Erkrankungen, 2015,

    CrossRef

  3. 3
    Cindy K. Barha, Liisa A.M. Galea, The hormone therapy, Premarin, impairs hippocampus-dependent spatial learning and memory and reduces activation of new granule neurons in response to memory in female rats, Neurobiology of Aging, 2013, 34, 3, 986

    CrossRef

  4. 4
    Michael T. Murray, Textbook of Natural Medicine, 2013,

    CrossRef

  5. 5
    Tatjana A. Ishunina, Dick F. Swaab, Decreased alternative splicing of estrogen receptor-α mRNA in the Alzheimer's disease brain, Neurobiology of Aging, 2012, 33, 2, 286

    CrossRef

  6. 6
    M. Llanero Luque, J.M. Ruiz Sánchez de León, P. Medrano Izquierdo, C. Fernández García, Tratamiento de la enfermedad de Alzheimer, Medicine - Programa de Formación Médica Continuada Acreditado, 2011, 10, 76, 5138

    CrossRef

  7. 7
    Javier Gómez-Pavón, Paloma González García, Inés Francés Román, Maite Vidán Astiz, José Gutiérrez Rodríguez, Gregorio Jiménez Díaz, Nuria Pilar Montero Fernández, Baldomero Álvarez Fernández, José María Jiménez Páez, Recomendaciones en la prevención de reacciones adversas a medicamentos en personas mayores con demencia, Revista Española de Geriatría y Gerontología, 2010, 45, 2, 89

    CrossRef

  8. 8
    Eef Hogervorst, Stephan Bandelow, Sex steroids to maintain cognitive function in women after the menopause: A meta-analyses of treatment trials, Maturitas, 2010, 66, 1, 56

    CrossRef

  9. 9
    Whitney Wharton, Maritza Dowling, Christine M. Khosropour, Cynthia Carlsson, Sanjay Asthana, Carey E. Gleason, Cognitive benefits of hormone therapy: Cardiovascular factors and healthy-user bias, Maturitas, 2009, 64, 3, 182

    CrossRef

  10. 10
    Vee Prasher, Anthony Fernando, Pharmacological treatment of dementia in people with learning disabilities, Advances in Mental Health and Learning Disabilities, 2009, 3, 3, 10

    CrossRef

  11. 11
    Jane Marjoribanks, Cindy Farquhar, Helen Roberts, Anne Lethaby, Long term hormone therapy for perimenopausal and postmenopausal women, The Cochrane Library,